0000000000470575

AUTHOR

Montserrat Vendrell

showing 6 related works from this author

Eventos cardiovasculares tempranos y tardíos en pacientes ingresados por neumonía adquirida en la comunidad

2020

Resumen Introduccion La neumonia adquirida en la comunidad se asocia al desarrollo de eventos cardiovasculares (ECV). El objetivo del estudio fue analizar los factores relativos al huesped, la gravedad y la etiologia que se asocian con la aparicion de estos eventos, tempranos y tardios, y su impacto en la mortalidad. Metodo Estudio prospectivo de cohortes multicentrico en pacientes ingresados por neumonia. Se recogieron ECV durante el ingreso, a los 30 dias (tempranos) y al ano (tardios) y la mortalidad. Resultados Doscientos dos de 1.967 (10,42%) pacientes presentaron ECV tempranos y 122 (6,64%) tardios. El 16% de la mortalidad al ano se atribuyo a complicaciones cardiovasculares. Los fact…

Pulmonary and Respiratory MedicineGynecology03 medical and health sciencesmedicine.medical_specialty0302 clinical medicine030228 respiratory systembusiness.industryMedicinebusinessArchivos de Bronconeumología
researchProduct

Primary ciliary dyskinesia in adults with bronchiectasis: Data from the Embarc registry

2018

Introduction: Primary ciliary dyskinesia (PCD) is an inherited cause of bronchiectasis where defects in motile cilia result in failure to clear mucus. Individuals have life-long productive cough and recurrent infections Methods: The embarc registry is a prospective pan-European observational study of adults with bronchiectasis. Data entered into the registry between March 2015 and Jan 2018 was assessed. Disease severity in PCD was compared to two age and gender matched cohorts, the first consisting of individuals with immune deficiency and a second with idiopathic disease. Results: 287/11204 individuals (2.6%) were reported to have PCD. 65% were female, reflecting the female predominance in…

medicine.medical_specialtyBronchiectasisbusiness.industryIncidence (epidemiology)Diseasemedicine.disease03 medical and health sciences0302 clinical medicineImmune system030228 respiratory systemInternal medicineCohortotorhinolaryngologic diseasesMotile ciliumMedicineSputum030212 general & internal medicinemedicine.symptombusinessPrimary ciliary dyskinesiaRespiratory infections
researchProduct

Diagnosis and treatment of bronchiectasis

2008

Bronchiectasis is the end result of several different diseases that share principles of management. The clinical course usually involves chronic bronchial infection and inflammation, which are associated with progression. The cause of bronchiectasis should always be investigated, particularly when it can be treated. We recommend evaluating etiology, symptoms, bronchial colonization and infection, respiratory function, inflammation, structural damage, nutritional status, and quality of life in order to assess severity and to monitor clinical course. Care should be supervised by specialized units, at least when there is a history of chronic bronchial infection, recurrent exacerbations, or a c…

medicine.medical_specialtyBronchiectasisExacerbationmedicine.drug_classbusiness.industryAntibioticsInflammationGeneral Medicinemedicine.diseaseQuality of lifemedicineEtiologySputumRespiratory functionmedicine.symptomIntensive care medicinebusiness
researchProduct

Early and late cardiovascular events in patients hospitalized for community-acquired pneumonia

2020

Abstract Introduction Community-acquired pneumonia increases the risk of cardiovascular events (CVE). The objective of this study was to analyze host, severity, and etiology factors associated with the appearance of early and late events and their impact on mortality. Method Prospective multicenter cohort study in patients hospitalized for pneumonia. CVE and mortality rates were collected at admission, 30-day follow-up (early events), and one-year follow-up (late events). Results In total, 202 of 1967 (10.42%) patients presented early CVE and 122 (6.64%) late events; 16% of 1-year mortality was attributed to cardiovascular disease. The host risk factors related to cardiovascular complicatio…

medicine.medical_specialtybusiness.industryPneumonia severity indexMortality rateGeneral MedicineDiseasemedicine.diseasePneumoniaCommunity-acquired pneumoniaInternal medicinemedicineEtiologyRisk factorbusinessCohort studyArchivos de Bronconeumología (English Edition)
researchProduct

Diagnóstico y tratamiento de las bronquiectasias

2008

Bronchiectasis is the end result of several different diseases that share principles of management. The clinical course usually involves chronic bronchial infection and inflammation, which are associated with progression. The cause of bronchiectasis should always be investigated, particularly when it can be treated. We recommend evaluating etiology, symptoms, bronchial colonization and infection, respiratory function, inflammation, structural damage, nutritional status, and quality of life in order to assess severity and to monitor clinical course. Care should be supervised by specialized units, at least in cases of chronic bronchial infection, recurrent exacerbations, or when there is a ca…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyBronchiectasisExacerbationbusiness.industrymedicine.drug_classAntibioticsInflammationmedicine.diseaseQuality of lifeInternal medicinemedicineEtiologySputumRespiratory functionmedicine.symptombusinessArchivos de Bronconeumología
researchProduct

Immunofluorescence Analysis as a Diagnostic Tool in a Spanish Cohort of Patients with Suspected Primary Ciliary Dyskinesia

2020

Primary ciliary dyskinesia (PCD) is an autosomal recessive rare disease caused by an alteration of ciliary structure. Immunofluorescence, consisting in the detection of the presence and distribution of cilia proteins in human respiratory cells by fluorescence, has been recently proposed as a technique to improve understanding of disease-causing genes and diagnosis rate in PCD. The objective of this study is to determine the accuracy of a panel of four fluorescently labeled antibodies (DNAH5, DNALI1, GAS8 and RSPH4A or RSPH9) as a PCD diagnostic tool in the absence of transmission electron microscopy analysis. The panel was tested in nasal brushing samples of 74 patients with clinical suspic…

PCD antibody cilia immunofluorescence primary ciliary dyskinesiaPathologymedicine.medical_specialtyPrimary Ciliary DyskinesiaImmunofluorescencelcsh:MedicineImmunoglobulinsImmunofluorescenceArticleImmunofluorescència03 medical and health sciences0302 clinical medicinePrimary ciliary dyskinesiaCiliary axonemeantibodymedicineotorhinolaryngologic diseasesCiliaRespiratory systemAntibody030304 developmental biologyPrimary ciliary dyskinesia0303 health sciencesmedicine.diagnostic_testbiologybusiness.industryCiliumlcsh:RciliaGeneral Medicinemedicine.diseasePCD030228 respiratory systemDiscinesia ciliar primàriaCohortbiology.proteinAntibodybusinessImmunoglobulinesRare disease
researchProduct